Astria Therapeutics (ATXS) Interest & Investment Income: 2017-2018
Historic Interest & Investment Income for Astria Therapeutics (ATXS) over the last 2 years, with Dec 2018 value amounting to $173,000.
- Astria Therapeutics' Interest & Investment Income rose 440.62% to $173,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $425,000, marking a year-over-year increase of 165.62%. This contributed to the annual value of $425,000 for FY2018, which is 165.62% up from last year.
- Per Astria Therapeutics' latest filing, its Interest & Investment Income stood at $173,000 for Q4 2018, which was down 2.26% from $177,000 recorded in Q3 2018.
- Astria Therapeutics' 5-year Interest & Investment Income high stood at $177,000 for Q3 2018, and its period low was $32,000 during Q4 2017.
- For the 2-year period, Astria Therapeutics' Interest & Investment Income averaged around $73,125, with its median value being $43,500 (2017).
- The largest annual percentage gain for Astria Therapeutics' Interest & Investment Income in the last 5 years was 440.62% (2018), contrasted with its biggest fall of 17.95% (2018).
- Astria Therapeutics' Interest & Investment Income (Quarterly) stood at $32,000 in 2017, then spiked by 440.62% to $173,000 in 2018.
- Its Interest & Investment Income stands at $173,000 for Q4 2018, versus $177,000 for Q3 2018 and $43,000 for Q2 2018.